Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Delic Holdings Corp (OP: DELCF ) N/A UNCHANGED Last Price Updated: 11:49 AM EST, Dec 19, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Delic Holdings Corp < Previous 1 2 Next > Rolling The Perfect Joint For A Quick & Efficient High, Researchers Say It Doesn't Involve Strong Weed July 04, 2023 If you want to get very high quickly, according to a freelance science writer sharing her knowledge in the oldest continuously published magazine in the United States, you might assume smoking the... Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered Via Benzinga In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend? March 15, 2023 Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their... Via Benzinga Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month December 25, 2022 Today's article highlights the performance of the munKNEE Psychedelic Drug Stocks Index which tracks the six (6) largest psychedelic stocks researching the treatment of mental illnesses based on the... Via Talk Markets Delic Teams Up With Biotech Co. GT Research October 26, 2021 Psychedelics wellness platform Delic Holding Corp Inc. (CSE: Via Benzinga Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD December 11, 2022 Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. Via Talk Markets Psychedelic Drug Stocks Index Has A Good Week November 27, 2022 We track six psychedelic stocks researching the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances. Via Talk Markets The Psychedelic Drug Stocks Index Continued To Plummet Last Week November 07, 2022 In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. Via Talk Markets October Recap: Major Psychedelic Drug Stocks Declined 9.9% October 27, 2022 In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD. Via Talk Markets Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD September 25, 2022 Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. Via Talk Markets Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic September 22, 2022 Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada. Via Benzinga Delic Completes Offering Of Debentures August 01, 2022 Delic Holdings Corp (OTCQB: DELCF) (CSE:DELC) (FRA: 6X0) completed the sale of 1,240 units at a price of $1,000 per unit for aggregate gross proceeds of $1.24 million, on July 27, 2022. Via Benzinga Strategic Cannabis Execs Making Changes At Companies You Know: Curaleaf, Valens, Copperstate & Delic July 22, 2022 As Benzinga Cannabis Capital Conference returns (September 13-14) in Chicago, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes... Via Benzinga Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion July 22, 2022 Delic Holdings Corp. (OTCQB: DELCF) owns and operates an umbrella of psychedelics-related businesses towards improving access to health benefits across the U.S., including one of the largest chain of... Via Benzinga Nation's Largest Ketamine Therapy Provider Offers Patient Resource For Holistic Mental Health Treatments June 30, 2022 Through subsidiary Ketamine Wellness Centers (KWC), Delic Holdings Corp (OTCQB: DELCF) has launched the Ketamine Wellness Integrative Therapist Directory. Via Benzinga Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress May 19, 2022 After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics. Via Benzinga Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies May 17, 2022 The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. Via Benzinga Delic Holdings Provides Default Status Update May 16, 2022 Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) provided a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease... Via Benzinga Veterans In Arizona Will Have Access To Ketamine Therapy At No Out-Of-Pocket Cost May 12, 2022 Delic Holdings Corp’s (OTCQB: DELCF) Ketamine Wellness Center will provide military veterans in Arizona with ketamine therapy for treatment-resistant depression (TRD) and PTSD. Via Benzinga Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs May 10, 2022 Psychedelics policy action took center stage this week. Via Benzinga What Is NAD+, Ketamine Wellness Center's New Therapy? May 04, 2022 Delic Holdings Corp.’s (OTCQB: DELCF) subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy. Via Benzinga Red White & Bloom, Delic And Chalice To Delay Filing Earnings Reports May 04, 2022 It seems cannabis companies have joined the ongoing trend of filing their financial statements late. As reported new additions to the club are Delic Holdings and Chalice Brands, while Red White & Bloom... Via Benzinga SRAX (NASDAQ: SRAX) Releases Replays From 2022 Cannabis And Psychedelic Conference April 27, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Delic Labs Receives Exemption To Conduct Research On MDMA, LSD And Other Psychedelic Compounds April 13, 2022 Via Benzinga Ketamine Wellness Centers Offering FDA Approved Esketamine Treatment For Major Depressive Disorder March 30, 2022 Ketamine Wellness Centers subsidiary of Delic Holdings Corp (OTCQB: DELCF) (CSE:DELC) (FRA:6X0), has expanded its treatment options to include SPRAVATO nasal spray. The KWC clinics located in Houston,... Via Benzinga Ketamine Wellness Centers Openes Mental Health Clinic In Reno Nevada March 16, 2022 Ketamine Wellness Centers, the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp (CSE:DELC) ... Via Benzinga Cannabis Dispensary Roundup: Delic Holdings, Ayr Wellness, High Tide January 18, 2022 Delic Holdings Announces Grand Opening Of Salt Lake City Clinic Delic Holdings Corp (CSE: Via Benzinga Delic Introduces Industry's First Family Support & Education Program At Ketamine Wellness Centers November 18, 2021 On Thursday, Delic Holdings Corp (CSE:DELC) (OTCQB:... Via Benzinga Delic Closes $10M Merger With Chain Of Ketamine Clinics November 09, 2021 Psychedelic wellness company Delic Holdings Corp. (CSE:DELC) ... Via Benzinga Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation November 01, 2021 The Week In Psychedelics: Via Benzinga Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
